Tilray Brands (TLRY) Gross Margin Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Gross Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Tilray Brands | 541.05 Mn | 306.41 Mn | 90.52 Mn | 201.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 201.00 |
| Feb 28, 2026 | -141.00 |
| Nov 30, 2025 | -259.00 |
| Aug 31, 2025 | -242.00 |
| May 31, 2025 | -570.00 |
| Feb 28, 2025 | 177.00 |
| Nov 30, 2024 | 455.00 |
| Aug 31, 2024 | 487.00 |
| May 31, 2024 | -64.00 |
| Feb 29, 2024 | 3,426.00 |
| Nov 30, 2023 | -528.00 |
| Aug 31, 2023 | -675.00 |
| May 31, 2023 | 4,086.00 |
| Feb 28, 2023 | -3,426.00 |
| Nov 30, 2022 | 863.00 |
| Aug 31, 2022 | 140.00 |
| May 31, 2022 | -2,021.00 |
| Feb 28, 2022 | 164.00 |
| Nov 30, 2021 | -614.00 |
| Aug 31, 2021 | 58.00 |